胎儿心脏肿瘤:53例的超声心动图、临床结局与遗传学分析
对53例经标准化胎儿超声心动图检出心脏肿瘤的胎儿及其父母等相关家庭成员行TSC基因检测,37例检出TSC1或TSC2致病或疑似致病突变(自发25例、家族性12例);多发性肿瘤组基因阳性比例86%,单发肿瘤组31%,差异有统计学意义;38例尸检中36例病理确诊心脏横纹肌瘤。作者建议对超声心动图疑似心脏横纹肌瘤的胎儿及家庭成员行产前TSC基因检测。
要点
- 胎儿心脏肿瘤以心脏横纹肌瘤最常见,检出后应想到TSC可能。
- 多发肿瘤者TSC基因阳性比例86%,单发者31%,两者差异有统计学意义。
- 无论单发或多发,心脏横纹肌瘤与TSC均高度相关。
核心结论
- 心脏横纹肌瘤是胎儿最常见的心脏肿瘤,无论单发或多发均与TSC高度相关。
- 作者建议对胎儿超声心动图疑似心脏横纹肌瘤的胎儿及其家庭成员行产前TSC基因检测。
- 基因诊断阳性有助于咨询和规划新生儿治疗。
研究设计与样本
- 研究纳入53例妊娠女性,其胎儿经标准化胎儿超声心动图检出心脏肿瘤。
- 胎儿、母亲和父亲(必要时包括其他相关家庭成员)接受家族性TSC基因检测。
- 记录活产儿临床检查及终止妊娠病例尸检的相关病理特征。
关键影像表现/征象
- 胎儿超声心动图检出37例多发心脏肿瘤、16例单发心脏肿瘤。
诊断标准与关键数值
- 53例胎儿及家庭TSC基因检测均成功,37例检出TSC1(6例)或TSC2(31例)致病或疑似致病突变。
- 37例突变中25例为自发突变、12例为家族性突变。
- TSC基因阳性组多发肿瘤比例86%,阴性组31%,两组单发与多发肿瘤比例差异有统计学意义。
- 多发或单发肿瘤与TSC突变类型无关。
- 尸检多发性横纹肌瘤胎儿中93%携带TSC1或TSC2突变,单发心脏横纹肌瘤中71%携带TSC1或TSC2突变。
临床应用与阅片要点
- 胎儿超声心动图检出疑似心脏横纹肌瘤时,作者建议对胎儿及家庭成员行产前TSC基因检测。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To analyze the imaging and clinical features of fetal cardiac tumors, and to explore the relationship between tuberous sclerosis complex (TSC) and cardiac rhabdomyoma in the fetus.
METHODS: Fifty-three women pregnant with a fetus affected by cardiac tumor(s) were examined by standardized fetal echocardiography (FE), and fetuses, mothers and fathers, including other relevant family members if necessary, underwent familial TSC genetic testing. Relevant pathological features, including pathological findings at clinical examination of liveborn infants and autopsy findings in terminated cases, were noted.
RESULTS: Of the 53 fetuses, 37 had multiple cardiac tumors and 16 had a single cardiac tumor detected by FE. In all 53 fetuses and their families, TSC genetic testing was successful, showing that 37 of the fetuses had a TSC1 (n = 6) or TSC2 (n = 31) pathogenic or suspected pathogenic mutation, of which 25 were spontaneous and 12 were familial mutations. The proportion of single and multiple cardiac tumors at FE was significantly different between the group of fetuses with positive genetic test results and that with negative results for TSC (31% and 86%, respectively), although the presence of multiple or single tumors was not associated with the type of TSC mutation. The decision to terminate the pregnancy was made by 45 women and their families, and eight fetuses were liveborn. Autopsy was performed in 38 fetuses, which revealed 36 cases with pathologically confirmed cardiac rhabdomyoma, one case of hemangioma and one case of fibroma. 93% of fetuses with multiple rhabdomyomas at autopsy and 71% of those with a single cardiac rhabdomyoma harbored a TSC1 or TSC2 mutation.
CONCLUSION: Cardiac rhabdomyoma is the most common cardiac tumor in the fetus. The correlation between cardiac rhabdomyoma and TSC is strong regardless of the presence of single or multiple tumors. For fetuses with suspected cardiac rhabdomyoma identified by FE, prenatal genetic testing for TSC of both fetus and family members is recommended. A positive genetic diagnosis can help in counseling and planning for neonatal treatment. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Chen J, Wang J, Sun H, et al. Fetal cardiac tumor: echocardiography, clinical outcome and genetic analysis in 53 cases. Ultrasound Obstet Gynecol. 2019. PMID: 29877000. doi:10.1002/uog.19108
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。